Linda Rogers, Cecile Tj Holweg, Hooman Pazwash, Jinnie Ko, Samuel Louie
{"title":"哮喘发病年龄不影响对奥玛珠单抗的反应。","authors":"Linda Rogers, Cecile Tj Holweg, Hooman Pazwash, Jinnie Ko, Samuel Louie","doi":"10.1177/14799731231159673","DOIUrl":null,"url":null,"abstract":"<p><strong>Trial registration: </strong>These studies were conducted before clinical trial registration was required; therefore, clinical trial registration numbers are not available.</p>","PeriodicalId":10217,"journal":{"name":"Chronic Respiratory Disease","volume":"20 ","pages":"14799731231159673"},"PeriodicalIF":3.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bf/a9/10.1177_14799731231159673.PMC10071096.pdf","citationCount":"0","resultStr":"{\"title\":\"Age of asthma onset does not impact the response to omalizumab.\",\"authors\":\"Linda Rogers, Cecile Tj Holweg, Hooman Pazwash, Jinnie Ko, Samuel Louie\",\"doi\":\"10.1177/14799731231159673\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Trial registration: </strong>These studies were conducted before clinical trial registration was required; therefore, clinical trial registration numbers are not available.</p>\",\"PeriodicalId\":10217,\"journal\":{\"name\":\"Chronic Respiratory Disease\",\"volume\":\"20 \",\"pages\":\"14799731231159673\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bf/a9/10.1177_14799731231159673.PMC10071096.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chronic Respiratory Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/14799731231159673\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chronic Respiratory Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/14799731231159673","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
Age of asthma onset does not impact the response to omalizumab.
Trial registration: These studies were conducted before clinical trial registration was required; therefore, clinical trial registration numbers are not available.
期刊介绍：
Chronic Respiratory Disease is a peer-reviewed, open access, scholarly journal, created in response to the rising incidence of chronic respiratory diseases worldwide. It publishes high quality research papers and original articles that have immediate relevance to clinical practice and its multi-disciplinary perspective reflects the nature of modern treatment. The journal provides a high quality, multi-disciplinary focus for the publication of original papers, reviews and commentary in the broad area of chronic respiratory disease, particularly its treatment and management.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
